Abstract
This chapter addresses the prevalence of diabetes mellitus (DM) in various countries according to geographic regions, as designated in an atlas published by the International Diabetes Federation in 2011.1 These include countries and territories in Europe, Africa, Middle East, North Africa, North America and Caribbean islands, South and Central America, South-East Asia and the Western Pacific Islands. Actual prevalence of DM (cases per 100 population) is expressed not only specifically for each individual country (national value) but more importantly, corrected by the population, age structure (comparative value) and also as an estimate of DM trend in 2030. It can be seen that in all countries (Tables 1–5) the prevalence of DM is on rise. A substantial contributing factor to the rise is the steady increase in body weight and obesity in many parts of the world. Economic stability and technological progress promote obesity in European countries, the USA and in oil producing countries such as Saudi Arabia, United Arab Emirates and Kuwait. Also environmental factors, social trends toward higher energy intake and reduced energy expenditure also have a decisive role to play in the pathogenesis of overweight and DM.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 2011.
Ginter E, Simko V. Diabetestype 2 pandemic in 21st century. Bratisl Med J 2010; 111:134–137.
Ahmed O, Boschi-Pinto C, Lopez AD et al. Age standardization of rates: a new WHO standard. Geneva, World health organization 2001.
Harris R, Donahue K, Rathore SS et al. Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services task force. ann Intern Med 2003; 138:215–229.
Ginter E, Simko V. adult obesity at the beginning of the 21st century: epidemiology, pathophysiology and health risk. Bratisl Med J 2008; 109:224–230.
Mokad AH, Ford ES, Bouman BA et al. Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA 2003; 289:76–79.
Hossain P, Kawar B, Nahas ME et al. Obesity and diabetes in the developing word—a growing challenge. N Engl J Med 2007; 356:213–215.
Morrish NJ, Wang SL, Stevens LK et al. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44 (Suppl. 2):S14–S21.
Roglic G, Unwin N, Bennet PH et al. the burden of mortality attributable to diabetes. Diabetes care 2005; 28:2130–2135.
Narayan V, Boyle JP, Geiss LS et al. Impact of recent increase in incidence on future diabetes burden U.S., 2005–2050. Diabetes care 2006; 29:2114–2116.
Chiefari E, Tanyolaç S, Paonessa F et al. Functional variants of the HMGA1 gene and type 2 diabetes mellitus. JAMA 2011; 305sn9):903–912.
McCarthy MI. Genomics, type 2 diabetes and obesity. N Engl J Med 2010; 363:2339–2350.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Ginter, E., Simko, V. (2013). Global Prevalence and Future of Diabetes Mellitus. In: Ahmad, S.I. (eds) Diabetes. Advances in Experimental Medicine and Biology, vol 771. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5441-0_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5441-0_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5440-3
Online ISBN: 978-1-4614-5441-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)